EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Slc5a6-deficient mouse model reveals metabolically driven cardiomyopathy with therapeutic potential for vitamin-based intervention

Millie O Fullerton, Lauren C Phillips, Rachael E Redgrave, Luke Spray, Vincent Haufroid, George Merces, Scott T Kerridge, Gavin D Richardson, Nathalie Mercier, Dominique Roland, Rebecca Crossley, Andrew Dh Morgan und 4 weitere

JCI Insight · 2026

DOI: 10.1172/jci.insight.200381 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JCI Insight, 2026. Verfasst von Millie O Fullerton und 15 weiteren Autor:innen. Beteiligte Einrichtung: Biosciences Institute, Newcastle University, Newcastle upon Tyne, United Kingdom. Hauptthemen laut MEDLINE: Cardiomyopathy, Dilated, Vitamins, Cardiomyopathies. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The sodium-dependent multivitamin transporter, encoded by SLC5A6 , mediates cellular uptake of biotin and pantothenic acid, essential cofactors for energy metabolism. We identified 2 families with SLC5A6 mutations presenting with early-onset dilated cardiomyopathy (DCM). To investigate the link between vitamin deficiency and cardiomyopathy, we generated a cardiac-specific SLC5A6 -knockout ( Slc5a6 cKO ) mouse model and evaluated the impact of vitamin supplementation. Slc5a6 cKO mice developed progressive cardiac dysfunction, culminating in cardiac pathology and premature death at 26 weeks; earlier stages exhibited cardiomyocyte hypertrophy, fibrosis, impaired coenzyme A synthesis, and metabolic imbalance, indicating progression toward cardiomyopathy. Cardiac magnetic resonance imaging and ECG confirmed progressive functional decline. Proteomic analysis revealed early mitochondrial metabolic disruption and extracellular matrix protein upregulation at 8 weeks, preceding overt cardiac dysfunction. Strikingly, vitamin supplementation from preconception onwards prevented the cardiac phenotype, preserving cardiac structure, function, morphology and survival. This paralleled the clinical outcome in one patient who received early vitamin treatment, compared with another who required a heart transplant without vitamin treatment. This study establishes a direct link between SLC5A6 -mediated vitamin transport, mitochondrial function, and cardiac health. It highlights how vitamin deficiency contributes to cardiomyopathy pathogenesis and supports early vitamin supplementation as a potential therapeutic strategy for metabolic cardiomyopathies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiomyopathy, DilatedVitaminsCardiomyopathiesAnimalsMiceDisease Models, AnimalMice, KnockoutFemaleHumansMaleBiotinMyocardium

Stichwörter der Autor:innen

CardiologyCardiovascular diseaseMetabolismMouse models

Substanzen

VitaminsBiotin

Autor:innen und Institutionen

  • Biosciences Institute, Newcastle University, Newcastle upon Tyne, United Kingdom.
  • Department of Pharmacology, University of Oxford, United Kingdom.
  • Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom.
  • Louvain Center for Toxicology and Applied Pharmacology (LTAP), Institut de Recherche Expérimentale et Clinique (IREC), UCLouvain, Brussels, Belgium.
  • Image Analysis Unit, Newcastle University, Newcastle upon Tyne, United Kingdom.
  • Department of Pediatrics, CHU HELORA Jo, La Louvière, Belgium.

Zitieren

APA

Fullerton, M. O., Phillips, L. C., Redgrave, R. E., Spray, L., Haufroid, V., Merces, G., Kerridge, S. T., Richardson, G. D., Mercier, N., Roland, D., Crossley, R., Morgan, A. D., Dewulf, J. P., Burn, J., Bamforth, S. D., & Phillips, H. M. (2026). A Slc5a6-deficient mouse model reveals metabolically driven cardiomyopathy with therapeutic potential for vitamin-based intervention. JCI Insight. https://doi.org/10.1172/jci.insight.200381

Vancouver

Fullerton MO, Phillips LC, Redgrave RE, Spray L, Haufroid V, Merces G, et al. A Slc5a6-deficient mouse model reveals metabolically driven cardiomyopathy with therapeutic potential for vitamin-based intervention. JCI Insight. 2026. doi:10.1172/jci.insight.200381

BibTeX
@article{Fullerton2026,
  author = {Fullerton, Millie O and Phillips, Lauren C and Redgrave, Rachael E and Spray, Luke and Haufroid, Vincent and Merces, George and Kerridge, Scott T and Richardson, Gavin D and Mercier, Nathalie and Roland, Dominique and Crossley, Rebecca and Morgan, Andrew Dh and Dewulf, Joseph P and Burn, John and Bamforth, Simon D and Phillips, Helen M},
  title = {A Slc5a6-deficient mouse model reveals metabolically driven cardiomyopathy with therapeutic potential for vitamin-based intervention},
  journal = {JCI Insight},
  year = {2026},
  doi = {10.1172/jci.insight.200381}
}
Kostenlos starten →